Journal of Evidence-Based Dental Practice
Volume 4, Issue 2 , Pages 146-147, June 2004

About 6% of sites treated with a chlorhexidine chip experience a minor adverse event

Abstract 

Original Article

Soskolne WA, Proskin HM, Stabholz A. Probing depth changes following 2 years of periodontal maintenance therapy including adjunctive controlled release of chlorhexidine. J Periodontol 2003;74(4):420–71.

Level of Evidence

4

Purpose

To examine the adjunctive use of CHX chip for routine periodontal maintenance therapy over 2 years

Source of Funding

Grant from Dexcel Pharma Technologies Ltd. The first author of the study, Dr. Soskolne, is a consultant for from Dexcel Pharma Technologies, and Howard Proskin is the chief executive officer

Type of Study/Design

Phase IV trial—longitudinal observational study (no control group)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 20.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1532-3382(04)00047-8

doi:10.1016/j.jebdp.2004.03.017

Journal of Evidence-Based Dental Practice
Volume 4, Issue 2 , Pages 146-147, June 2004

Article Tools